Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?

Bibliographic Details
Main Author:	Jay B. Wish
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Kidney Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059520301801

Similar Items

Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
by: Jie Song, et al.
Published: (2023-10-01)

Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling EraPlain-Language Summary
by: Borut Cizman, et al.
Published: (2020-09-01)

Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients.
by: Kamalas Amnuay, et al.
Published: (2019-09-01)

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
by: Ichiei Narita, et al.
Published: (2022-01-01)

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.
by: Ichiei Narita, et al.
Published: (2022-01-01)

Correction to: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
by: Ylenia Ingrasciotta, et al.
Published: (2020-07-01)

Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress
by: Srdjan Nikolovski, et al.
Published: (2024-10-01)

Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis
by: Shizuka Kobayashi, et al.
Published: (2022-12-01)

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019-01-01)

Guilty Until Proven Guilty
by: Shivangi Narayan
Published: (2021-09-01)

Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes
by: Zachary Gowanlock, et al.
Published: (2017-08-01)

Appropriate Use of Inpatient Erythropoiesis Stimulating Agents
by: Chenghao Cui, et al.
Published: (2024-11-01)

Helicobacter pylori and Duodenal Ulcer: Guilty as Charged
by: SD Shafran, et al.
Published: (1994-01-01)

Religion! Guilty as charged!? A phenomenological appraisal
by: John Chijioke Madubuko
Published: (2023-10-01)

Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
by: Tilman B. Drüeke
Published: (2018-11-01)

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
by: Patrick Biggar, et al.
Published: (2017-09-01)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
by: Sun-Hee Park
Published: (2018-09-01)

Dissociative Identity Disorder and the Law: Guilty or Not Guilty?
by: Stefane M. Kabene, et al.
Published: (2022-08-01)

Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilization
by: Tomoyuki Kawano, et al.
Published: (2017-05-01)

Guilty, or not guilty?: a short story of propofol abuse
by: Sangseok Lee
Published: (2013-11-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Guilty of not doing that!
by: Marco Mazzocca
Published: (2020-12-01)

Guilty wives /
by: Patterson, James, 1947-
Published: (2012)

Pleading guilty /
by: 376768 Turow, Scott
Published: (1993)

Guilty creatures /
by: 363835 Welfare, Sue
Published: (2001)

Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review
by: Jorien Laermans, et al.
Published: (2022-10-01)

Hyporesponsiveness of intestinal dendritic cells to TLR stimulation is limited to TLR4.
by: Cerovic, V, et al.
Published: (2009)

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
by: Hirokazu Honda, et al.
Published: (2016-01-01)

Cancer, meta-analysis and reporting biases: the case of erythropoiesis-stimulating agents
by: Thomy Tonia, et al.
Published: (2013-05-01)

The Effect of Erythropoiesis-Stimulating Agents on Platelet Aggregation in Peritoneal Dialysis Patients
by: Serkan Bakırdöğen, et al.
Published: (2019-11-01)

Anaemia and heart failure: is there still a role for erythropoiesis-stimulating agents?
by: Massimo Volpe, et al.
Published: (2017-04-01)

Mechanisms of hemoglobin cycling in anemia patients treated with erythropoiesis-stimulating agents.
by: David J Jörg, et al.
Published: (2023-01-01)

Mechanisms of hemoglobin cycling in anemia patients treated with erythropoiesis-stimulating agents
by: David J. Jörg, et al.
Published: (2023-01-01)

A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
by: Monojit Das, et al.
Published: (2022-09-01)

Erythropoiesis Stimulation in Patients with Postoperative Anemia
by: D. B. Borisov, et al.
Published: (2013-08-01)

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes
by: Juan Carlos Caballero, et al.
Published: (2024-01-01)

ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage.
by: Takahiro Kuragano, et al.
Published: (2016-01-01)

PATRIARCHALITY IS GUILTY FOR EVERYTHING
by: Ana Ashtalkovska
Published: (2016-11-01)

Nudges to reason: not guilty
by: Levy, N
Published: (2017)